Viewing Study NCT06316557



Ignite Creation Date: 2024-05-06 @ 8:15 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06316557
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-18
First Post: 2024-03-12

Brief Title: High-frequency rTMS on the Cerebellar to Improve Post-stroke Cognitive Impairment
Sponsor: Beijing Tiantan Hospital
Organization: Beijing Tiantan Hospital

Study Overview

Official Title: High-frequency Repetitive Transcranial Magnetic Stimulation on the Cerebellar Hemisphere to Improve Post-stroke Cognitive Impairment
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: HOPE
Brief Summary: The objective of this clinical trial is to investigate the effectiveness and safety of repetitive transcranial magnetic stimulation rTMS in the cerebellum for individuals with post-stroke cognitive impairment Participants will undergo rTMS in the cerebellar hemisphere opposite the lesion site once daily for a total of five days
Detailed Description: The primary objective of this clinical trial is to investigate the effectiveness and safety of high-frequency repetitive transcranial magnetic stimulation rTMS in the cerebellum for individuals with post-stroke cognitive impairment The trial aims to answer two main questions 1 What is the effectiveness of high-frequency rTMS in improving post-stroke cognitive impairment 2 Is high-frequency rTMS in the cerebellum safe for individuals with post-stroke cognitive impairment Participants will undergo 5Hz rTMS in the cerebellar opposite the lesion site once daily for a total of five days The control group will receive sham rTMS with the same parameters and positions By comparing the effectiveness of rTMS for post-stroke cognitive impairment between the two groups researchers will assess the potential benefits of rTMS

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None